Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Future FinTech Group
FTFT
$1.52M
| $194K | ﹤0.01% |
17
-1
| -6% | -$12.1K |
|
|
ELGX
2627
DELISTED
Endologix Inc
ELGX
| $194K | ﹤0.01% |
+1,110
| New | +$191K |
|
|
SOCB
2628
DELISTED
SOUTHCOAST FINANCIAL CORP
SOCB
| $193K | ﹤0.01% |
33,255
+4,200
| +14% | +$24.4K |
|
|
ELSE
2629
DELISTED
Electro-Sensors
ELSE
| $192K | ﹤0.01% |
47,800
+3,000
| +7% | +$12K |
|
2630
Gray Media Inc
GTN.A
$612M
| $192K | ﹤0.01% |
14,900
+1,400
| +10% | +$13.1K |
|
|
THMO
2631
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $191K | ﹤0.01% |
21
-4
| -16% | -$31.8K |
|
|
GDEN
2632
DELISTED
Golden Entertainment
GDEN
| $190K | ﹤0.01% |
24,000
-1,700
| -7% | -$13.8K |
|
2633
IT Tech Packaging
ITP
$2.88M
| $190K | ﹤0.01% |
7,130
+1,500
| +27% | +$34.6K |
|
|
GIGA
2634
DELISTED
Giga-Tronics Inc
GIGA
| $189K | ﹤0.01% |
205,000
-600
| -0.3% | -$615 |
|
2635
Imunon
IMNN
$6.64M
| $188K | ﹤0.01% |
+18
| New | +$216K |
|
2636
Silicon Motion
SIMO
$8.45B
| $188K | ﹤0.01% |
13,262
-151,417
| -92% | -$2.07M |
|
2637
Vista Gold
VGZ
$328M
| $186K | ﹤0.01% |
490,500
+27,000
| +6% | +$11.2K |
|
|
ATL
2638
DELISTED
ATLATSA RES CORP RESOURCES CORP (F)
ATL
| $186K | ﹤0.01% |
323,700
+120,800
| +60% | +$55.3K |
|
|
GAI
2639
DELISTED
GLOBAL-TECH ADVANCED INNOVATIONS INC
GAI
| $186K | ﹤0.01% |
29,400
-3,100
| -10% | -$21.1K |
|
|
IRC
2640
DELISTED
INLAND REAL ESTATE CORP
IRC
| $186K | ﹤0.01% |
17,700
-212,000
| -92% | -$2.23M |
|
|
DX
2641
Dynex Capital
DX
$3.23B
| $184K | ﹤0.01% |
+7,680
| New | +$193K |
|
|
SURG
2642
DELISTED
SYNERGETICS USA, INC.
SURG
| $184K | ﹤0.01% |
50,701
+38,001
| +299% | +$155K |
|
|
WSCI
2643
DELISTED
WSI Industries Inc
WSCI
| $183K | ﹤0.01% |
30,100
-900
| -3% | -$5.46K |
|
|
OCRX
2644
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $181K | ﹤0.01% |
+13,949
| New | +$130K |
|
2645
Origin Agritech
SEED
$12.7M
| $180K | ﹤0.01% |
14,180
-1,440
| -9% | -$23.4K |
|
|
MICR
2646
DELISTED
Micron Solutions, Inc.
MICR
| $180K | ﹤0.01% |
56,900
+800
| +1% | +$2.71K |
|
|
CTHR
2647
DELISTED
Charles & Colvard Ltd
CTHR
| $178K | ﹤0.01% |
3,530
-19,000
| -84% | -$1.07M |
|
|
FUBC
2648
DELISTED
1st United Bancorp (Florida)
FUBC
| $178K | ﹤0.01% |
23,400
+11,400
| +95% | +$87.8K |
|
|
INVT
2649
DELISTED
Inventergy Global, Inc.
INVT
| $177K | ﹤0.01% |
3,647
-50
| -1% | -$1.27K |
|
2650
WidePoint Corp
WYY
$115M
| $173K | ﹤0.01% |
10,570
+6,410
| +154% | +$67.3K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.